Whitehawk Therapeutics appoints Vijay Iyengar to board
Whitehawk Therapeutics said Vijay Iyengar was appointed as a Class III director, effective September 9, 2026. The item cites an original SEC filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.